Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21
14 June 2016 - 10:30PM
Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
renal disease, today announced it will present at the JMP Life
Science Conference in New York City on Tuesday, June 21, 2016 at
1:30 p.m. ET.
A live audio webcast of the presentation will be
accessible from Keryx’s website at http://investors.keryx.com
within the Investor Relations section under the “webcasts and
presentations” page. An archived version of the webcast will be
available for at least 15 days following the conclusion of the live
presentation.
About Keryx Biopharmaceuticals,
Inc. Keryx Biopharmaceuticals, with headquarters in
Boston, is focused on bringing innovative medicines to people with
renal disease. In December 2014, the company launched its first
FDA-approved medicine, Auryxia® (ferric citrate) in the United
States. In January 2014, ferric citrate was approved for use
in Japan, where it is being marketed as Riona® by Keryx's Japanese
partner, Japan Tobacco Inc. and Torii Pharmaceutical Co. Ltd. In
September 2015, the European Commission granted European market
authorization for Fexeric® (ferric citrate coordination complex).
For more information about Keryx, please visit www.keryx.com.
KERYX CONTACT:
Lora Pike
Senior Director, Investor Relations
T: 617-466-3511
lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Apr 2024 to May 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ): 0 recent articles
More News Articles